NEUROMODULATIONSVORRICHTUNG

European patent · EP4052756 · Deleted

Register entry

Publication number
EP4052756
Application number
EP22169569
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Aug 18, 2016
Published
Sep 7, 2022
Granted
May 15, 2024
Deleted
Mar 25, 2025
Reason
Annual fee unpaid
IPC classes
A61N 1/36 (2006.01)
Priority
US 201562208057 P 21.08.2015
Divided from
EP16760189
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 26, 2025

    Change

    Published in Swissreg on 26.03.2025

  2. Mar 25, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    25.03.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 25.03.2025

  3. May 29, 2024

    Owner

    Owner
    Galvani Bioelectronics Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom → Galvani Bioelectronics Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom

    Published in Swissreg on 29.05.2024

  4. May 15, 2024

    Granted

    Published in Swissreg on 15.05.2024

Parties

Holder

Galvani Bioelectronics Limited

GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB

Inventor

CARR, Michael, John

King of Prussia, 19406-0939, US

KWONG, Kevin, K.

King of Prussia, 19406, US

HUNSBERGER, Gerald, E.

King of Prussia, 19406, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.